ATF4 and breast neoplasm: Moreover, ATF4-deficient cells exhibited increased proliferation rates compared with proficient tumor cells implicating ATF4 in the anti-tumor effects of PKR and eIF2α-P in mouse NEU breast tumors (Fig. 3d).